Global Radioisotopes Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

Radioisotope, a radionuclide with radioactivity. It is an atomic nuclear unstable atom. Each atom also has many isotopes. Although the atomic order of each set of isotopes is the same, it has different atomic weights. If the atom is radioactive, it will be called a physical radioactive nuclear species or radioisotopes. The Radioisotopes market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Radioisotopes market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Radioisotopes Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Radioisotopes market are: NTP Radioisotopes ISOFLEX Parsisotope ZAG Zyklotron AG Nordion Most important types of Radioisotopes products covered in this report are: Iodine-131 (I-131) Lutetium-177 (Lu-177) Ir-192 Technetium-99m (Tc-99m) Most widely used downstream fields of Radioisotopes market covered in this report are: Medical Industrial Agriculture Archeology Commercial Space Exploration Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.